Irbesartan Patent Expiration

Irbesartan was first introduced by Sanofi Aventis Us Llc in its drug Avapro on Sep 30, 1997. 23 different companies have introduced drugs containing Irbesartan.


Irbesartan Patents

Given below is the list of patents protecting Irbesartan, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Avapro US6342247

(Pediatric)

Pharmaceutical compositions containing irbesartan Dec 07, 2015

(Expired)

Sanofi Aventis Us
Avapro US6342247 Pharmaceutical compositions containing irbesartan Jun 07, 2015

(Expired)

Sanofi Aventis Us



Irbesartan's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Irbesartan Generic API Manufacturers

Several generic applications have been filed for Irbesartan. The first generic version for Irbesartan was by Teva Pharmaceuticals Usa and was approved on Mar 30, 2012. And the latest generic version is by Ipca Laboratories Ltd and was approved on May 22, 2024.

Given below is the list of companies who have filed for Irbesartan generic, along with the locations of their manufacturing plants worldwide.